Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction

Details for Australian Patent Application No. 2007263936 (hide)

Owner Schwarz Pharma AG

Inventors Beyreuther, Bettina; Stohr, Thomas; Heers, Cara

Agent Davies Collison Cave

Pub. Number AU-A-2007263936

PCT Pub. Number WO2008/000513

Priority 06021470.7 12.10.06 EP; 06024241.9 22.11.06 EP; 06013655.3 30.06.06 EP; 06021469.9 12.10.06 EP

Filing date 29 June 2007

Wipo publication date 3 January 2008

International Classifications

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2008/000513 Priority application(s): WO2008/000513

27 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263939-Improved sgp130Fc dimers

2007263921-Novel tennis ball